ARTICLE SUMMARY:
At a time when many investors are turning away from medtech, Deerfield Management has increased the resources it has dedicated to this space, while also offering a unique set of capabilities supporting the firm’s life sciences investments, including a $1.6 billion fund and a research institute.
Medical devices are certainly not the area of choice for most investors these days.
